Literature DB >> 14598074

Natural history and clinical features of progressive supranuclear palsy: a clinical study.

C Diroma1, C Dell'Aquila, A Fraddosio, S Lamberti, R Mastronardi, I Russo, M De Mari, G Iliceto.   

Abstract

Progressive supranuclear palsy (PSP or Steele-Richardson-Olszewski syndrome) is one of the most-common types of atypical parkinsonism. To characterize the natural history and the clinical features of PSP, we reviewed the records of 25 patients followed in our clinic since 1991, with a clinical diagnosis of PSP according to NINDS and Golbe criteria. Progressive onset of early bilateral bradykinesia and postural instability with falls during the 5th decade strongly support the diagnosis of PSP in our patients. Pseudobulbar symptoms are very common at onset and during the course of the illness.

Entities:  

Mesh:

Year:  2003        PMID: 14598074     DOI: 10.1007/s10072-003-0117-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  8 in total

1.  Current and future treatments in progressive supranuclear palsy.

Authors:  Irene van Balken; Irene Litvan
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.598

Review 2.  Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy.

Authors:  Maria Stamelou; Jakob Schöpe; Stefan Wagenpfeil; Teodoro Del Ser; Jee Bang; Iryna Y Lobach; Phi Luong; Gesine Respondek; Wolfgang H Oertel; AdamL Boxer; Günter U Höglinger
Journal:  Mov Disord       Date:  2016-03-07       Impact factor: 10.338

3.  Progressive supranuclear palsy: progression and survival.

Authors:  Julieta E Arena; Stephen D Weigand; Jennifer L Whitwell; Anhar Hassan; Scott D Eggers; Günter U Höglinger; Irene Litvan; Keith A Josephs
Journal:  J Neurol       Date:  2015-12-24       Impact factor: 4.849

Review 4.  A Review of Treatment Options for Progressive Supranuclear Palsy.

Authors:  Maria Stamelou; Günter Höglinger
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

5.  Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study.

Authors:  Milica Jecmenica-Lukic; Igor N Petrovic; Tatjana Pekmezovic; Vladimir S Kostic
Journal:  J Neurol       Date:  2014-06-03       Impact factor: 4.849

6.  Challenges Faced by Patients With Progressive Supranuclear Palsy and their Families.

Authors:  Theresa Moore; Mark Guttman
Journal:  Mov Disord Clin Pract       Date:  2014-06-04

7.  Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.

Authors:  Sang-Wook Lee; Seong-Beom Koh
Journal:  J Mov Disord       Date:  2012-10-30

Review 8.  How to spot ocular abnormalities in progressive supranuclear palsy? A practical review.

Authors:  Onanong Phokaewvarangkul; Roongroj Bhidayasiri
Journal:  Transl Neurodegener       Date:  2019-07-10       Impact factor: 8.014

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.